0.25Open0.25Pre Close0 Volume51 Open Interest7.50Strike Price0.00Turnover294.79%IV50.51%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type-0.0609Delta0.0158Gamma58.60Leverage Ratio-0.0396Theta-0.0003Rho-3.57Eff Leverage0.0031Vega
Keros Therapeutics Stock Discussion
Keros Eyes Potential Sale: Board Weighs Strategic Options Amid Investor Interest
Clinical Trial Success: KER-065 Hits All Safety Targets, Shows Promise for DMD Treatment
No comment yet